🇦🇺 Australia Country × Condition
solid tumor adult Clinical Trials in Australia
Active clinical trials for solid tumor adult with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 2, Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇦🇺 Australia
Active Trials in Australia (4)
NCT05086692 Phase 1, Phase 2
Recruiting
A Beta-only IL-2 ImmunoTherapY Study
Enrollment
115 pts
Country
🇦🇺 Australia
Medicenna Therapeutics, Inc.
View Trial → NCT06003621 Phase 2
Recruiting
Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients
Enrollment
96 pts
Country
🇦🇺 Australia
Omico
View Trial → NCT06337084 Phase 1
Recruiting
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
Enrollment
12 pts
Country
🇦🇺 Australia
Monopar Therapeutics
View Trial → NCT06617169 Phase 1
Recruiting
Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors
Enrollment
12 pts
Country
🇦🇺 Australia
Monopar Therapeutics
View Trial → Frequently Asked Questions
How many solid tumor adult clinical trials are active in Australia?
There are currently 4 active clinical trials for solid tumor adult with sites in Australia, of which 4 are actively recruiting patients.
How can I join a solid tumor adult clinical trial in Australia?
To join a solid tumor adult clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are solid tumor adult trials in Australia?
Active solid tumor adult trials in Australia span Phase 1, Phase 2, Phase 2, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology